FDA set to approve Pfizer Vaccine for Kids between Ages 5 and 11
AP and Reuters report that U.S. health regulators said late Friday that kid-size doses of Pfizer’s COVID-19 vaccine appear highly effective at preventing symptomatic infections in elementary school children and caused no unexpected safety issues, as the U.S. weighs beginning vaccinations in youngsters. The Food and Drug Administration (FDA) posted its analysis of Pfizer’s data ahead of a public meeting next week to debate whether the shots are ready for […]
